Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$17.57 - $23.95 $943,509 - $1.29 Million
-53,700 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$11.6 - $19.27 $622,920 - $1.03 Million
53,700 New
53,700 $1.03 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14.5M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Crawford Lake Capital Management, LLC Portfolio

Follow Crawford Lake Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.